Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aziz Nazha

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Leukemia & Lymphoma|January 25, 2013
Prognostic implications and clinical characteristics associated with bone marrow fibrosis in patients with myelofibrosisAziz Nazha, Zeev Estrov, Jorge Cortes, et al.
NPJ Digital Medicine|April 15, 2020
Personalized predictions of patient outcomes during and after hospitalization using artificial intelligenceC Beau Hilton, Alex Milinovich, Christina Felix, et al.
Leukemia & Lymphoma|April 25, 2015
The Revised International Prognostic Scoring System (IPSS-R) is not predictive of survival in patients with secondary myelodysplastic syndromesAziz Nazha, David P Seastone, Michael Keng, et al.
Transplantation and Cellular Therapy|May 16, 2021
Impact of Epigenomic Hypermethylation at TP53 on Allogeneic Hematopoietic Cell Transplantation Outcomes for Myelodysplastic SyndromesWei Wang, Paul Auer, Tao Zhang, et al.
Blood|March 21, 2012
EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experienceElias Jabbour, Jorge Cortes, Aziz Nazha, et al.
Haematologica|April 26, 2012
Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemiaAziz Nazha, Jorge Cortes, Stefan Faderl, et al.
American Journal of Hematology|January 23, 2016
Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)Courtney D DiNardo, Guillermo Garcia-Manero, Sherry Pierce, et al.
JCO Clinical Cancer Informatics|July 18, 2023
Thirty-Day Unplanned Hospital Readmissions in Patients With Cancer and the Impact of Social Determinants of Health: A Machine Learning ApproachNickolas Stabellini, Aziz Nazha, Nikita Agrawal, et al.
Blood|August 22, 2025
Artificial Intelligence in HematologyAziz Nazha, Olivier Elemento, Sanjay Ahuja, et al.
Haematologica|August 15, 2015
Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromesAziz Nazha, David Seastone, Tom Radivoyevitch, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Leukemia & Lymphoma|January 25, 2013
Prognostic implications and clinical characteristics associated with bone marrow fibrosis in patients with myelofibrosisAziz Nazha, Zeev Estrov, Jorge Cortes, et al.
NPJ Digital Medicine|April 15, 2020
Personalized predictions of patient outcomes during and after hospitalization using artificial intelligenceC Beau Hilton, Alex Milinovich, Christina Felix, et al.
Leukemia & Lymphoma|April 25, 2015
The Revised International Prognostic Scoring System (IPSS-R) is not predictive of survival in patients with secondary myelodysplastic syndromesAziz Nazha, David P Seastone, Michael Keng, et al.
Transplantation and Cellular Therapy|May 16, 2021
Impact of Epigenomic Hypermethylation at TP53 on Allogeneic Hematopoietic Cell Transplantation Outcomes for Myelodysplastic SyndromesWei Wang, Paul Auer, Tao Zhang, et al.
Blood|March 21, 2012
EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experienceElias Jabbour, Jorge Cortes, Aziz Nazha, et al.
Haematologica|April 26, 2012
Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemiaAziz Nazha, Jorge Cortes, Stefan Faderl, et al.
American Journal of Hematology|January 23, 2016
Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)Courtney D DiNardo, Guillermo Garcia-Manero, Sherry Pierce, et al.
JCO Clinical Cancer Informatics|July 18, 2023
Thirty-Day Unplanned Hospital Readmissions in Patients With Cancer and the Impact of Social Determinants of Health: A Machine Learning ApproachNickolas Stabellini, Aziz Nazha, Nikita Agrawal, et al.
Blood|August 22, 2025
Artificial Intelligence in HematologyAziz Nazha, Olivier Elemento, Sanjay Ahuja, et al.
Haematologica|August 15, 2015
Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromesAziz Nazha, David Seastone, Tom Radivoyevitch, et al.
Pageof 13